Genus FY results are in line with expectations, with the expected YoY weakness in Genus ABS offset by a stronger performance from Genus PIC and Genus Asia. New guidance for 2017 has been issued, with an expected increase in R&D expenditure projected to result in broadly flat earnings YoY in constant currency. We retain our recent Sell recommendation on valuation grounds.
08 Sep 2016
N+1 Singer - Genus - FY2016 results in line; new guidance suggests flat earnings in FY2017
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Genus - FY2016 results in line; new guidance suggests flat earnings in FY2017
Genus plc (GNS:LON) | 1,739 173.9 0.6% | Mkt Cap: 1,148m
- Published:
08 Sep 2016 -
Author:
Dr Jens Lindqvist -
Pages:
3
Genus FY results are in line with expectations, with the expected YoY weakness in Genus ABS offset by a stronger performance from Genus PIC and Genus Asia. New guidance for 2017 has been issued, with an expected increase in R&D expenditure projected to result in broadly flat earnings YoY in constant currency. We retain our recent Sell recommendation on valuation grounds.